Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel i…

Organon's NEXPLANON receives U.S. FDA sNDA approval for extended duration of use up to five years, including data for use in ...

Organon wins FDA nod to expand use of Nexplanon birth control implant

Organon (OGN) has received FDA approval to expand the label of its birth control implant Nexplanon from its current three ...